世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バルビツール酸系薬剤の世界産業調査レポート、成長動向と競合分析 2022-2028年


Global Barbiturate Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

バルビツール酸系は、中枢神経抑制剤として作用します。バルビツール酸は、バルビツール酸という化学物質の誘導体です。市場にはさまざまなバルビツール酸系薬剤が出回っていますが、いずれも中枢神経系に鎮静作... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年10月31日 US$5,600
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

バルビツール酸系は、中枢神経抑制剤として作用します。バルビツール酸は、バルビツール酸という化学物質の誘導体です。市場にはさまざまなバルビツール酸系薬剤が出回っていますが、いずれも中枢神経系に鎮静作用を及ぼし、不安のために臨床的に処方されます。バルビツール酸系薬剤は、てんかん、不眠症、てんかん重積状態などの治療にも使用されます。バルビツール酸系薬剤は錠剤で販売されており、経口および静脈内投与が可能です。

報告書の概要
COVID-19のパンデミックとロシア・ウクライナ戦争の影響により、2022年に百万米ドルと推定される製品名の世界市場は、2028年までに百万米ドルの改訂サイズに達し、予測期間2022-2028年にCAGR%で成長すると予測されます。
バルビツール酸系薬剤は、米国で薬物乱用防止管理法の適用を受けるため、その製造と流通が厳しく管理されています。バルビツール酸系薬剤は、ガンマアミノ酪酸（GABA）と呼ばれる脳内の主要な神経伝達物質の1つの活性を高めることで作用します。GABAが増加すると、使用者の脳に鎮静作用が働きます。バルビツール酸塩の効果は、服用の種類や強さによって異なりますが、4時間から16時間持続します。

レポート対象範囲
この最新レポートでは、産業構造、売上高、収益、価格、粗利率を調査しています。主要生産者の生産拠点、市場シェア、業界ランキング、プロフィールを掲載しています。最新の政府規制、市場情報、業界データにアクセスするため、一次調査および二次調査を実施しています。データは、バルビツール酸系薬剤のメーカー、流通業者、エンドユーザー、業界団体、政府の産業局、業界誌、業界専門家、第三者データベース、弊社内データベースから収集しました。
本レポートでは、各地域のバルビツール酸塩薬物市場における主要企業についての考察も行っています。さらに、Barbiturate Drugsの世界市場における主要なドライバーと地域のダイナミクス、業界内の現在のトレンドについても解説しています。

主な対象企業
本セクションでは、研究者は、事業を展開している著名なプレーヤーと、激しい競争に対抗するために彼らが焦点を当てている戦略について包括的な分析を行っています。また、著名なプレイヤーの会社概要と市場シェア分析もこのセクションで提供しています。さらに、専門家は、各プレイヤーの包括的な分析を行っています。彼らはまた、2017年から2022年の期間、メーカーの信頼性の高い売上高、収益、価格、市場シェアとランクデータを提供しています。本レポートの支援により、キープレイヤー、ステークホルダー、その他の参加者は、ビジネスにおける最近および今後の動向を把握することができ、さらに効率的な選択を行うことが可能になります。本調査報告書では、主要プレイヤーを以下に記載しています。
ファイザー
メルク
Eli Lilly
マイラン
サノフィ
テバ・ファーマシューティカル
大日本住友製薬
バウシュヘルス
オーク製薬
メダ・ファーマシューティカルズ

市場セグメント
本レポートでは、主要セグメントである「タイプ別」と「アプリケーション別」について調査しています。本レポートでは、業界の専門家により、その有利性と成長の可能性が検討されています。また、本レポートでは、2017-2028年までの売上高、収益、平均価格の予測データを、タイプ別、アプリケーション別セグメントに基づいて掲載しています。
バルビツール酸系薬剤の種類別セグメント
超短時間作用型バルビツール酸塩
短時間作用型バルビツール酸塩
長時間作用型バルビツール酸塩
配合剤
バルビツール酸塩製剤の用途別セグメント
病院薬局
小売薬局
オンライン薬局

主要地域と国
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域・国の成長を評価する際には、経済的、社会的、環境的、技術的、政治的要因が考慮されています。また、読者は2017-2028年までの各地域・国の金額と売上高データを手にすることができます。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの行く手を阻むブロックとして作用する可能性のある拘束要因や課題も含まれています。これは、ユーザーが気配りされ、ビジネスに関連する情報に基づいた意思決定を行うために役立ちます。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、パンデミック、ポストパンデミック、ロシア・ウクライナ戦争の間、バルビツール酸塩薬物市場のシナリオが世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面の変化を視野に入れながら行われています。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要な要因を取り上げています。

レポートには以下の内容が含まれます。
バルビツール酸系薬剤の世界市場の概要、売上高、収益、価格などを報告します。2017年～2021年の歴史的な市場収益/売上データ、2022年の予測、2028年までのCAGRの予測により、世界市場の動向を分析します。
バルビツール酸系薬剤の主要生産者を調査し、主要地域と国の売上高も記載しています。Barbiturate Drugsの今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国に焦点を当てます。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データおよび市場価値分析。

本レポートでは、2017年から2022年までのデータをもとに、バルビツール酸系薬剤の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てます。世界のBarbiturate Drugs市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別収益に基づいて分析します。本レポートは、ステークホルダーが競争環境を理解し、より多くの洞察を得て、ビジネスと市場戦略をより良い方法で位置づけるのに役立ちます。
本レポートでは、2017年から2028年までのタイプ別、用途別のセグメントデータ、売上、収益、価格などを分析しています。バルビツール酸系薬剤の売上、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
ファイザー、メルク、イーライリリー、マイラン、サノフィ、テバ製薬、大日本住友製薬、ボシュヘルス、オーク製薬など、世界の主要プレイヤーの詳細な企業プロファイル。


ページTOPに戻る


目次

List of Tables
Table 1. Global Barbiturate Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ultra-Short Acting Barbiturate
Table 3. Major Manufacturers of Short-Acting Barbiturate
Table 4. Major Manufacturers of Long-Acting Barbiturate
Table 5. Major Manufacturers of Combination Drugs
Table 6. Global Barbiturate Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Barbiturate Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Barbiturate Drugs Sales by Region (2017-2022) & (MT)
Table 9. Global Barbiturate Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Barbiturate Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Barbiturate Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Barbiturate Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 13. Global Barbiturate Drugs Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Barbiturate Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Barbiturate Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Barbiturate Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Barbiturate Drugs Market Trends
Table 18. Barbiturate Drugs Market Drivers
Table 19. Barbiturate Drugs Market Challenges
Table 20. Barbiturate Drugs Market Restraints
Table 21. Global Barbiturate Drugs Sales by Manufacturers (2017-2022) & (MT)
Table 22. Global Barbiturate Drugs Sales Share by Manufacturers (2017-2022)
Table 23. Global Barbiturate Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Barbiturate Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 25. Barbiturate Drugs Revenue Share by Manufacturers (2017-2022)
Table 26. Global Barbiturate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Barbiturate Drugs as of 2021)
Table 28. Key Manufacturers Barbiturate Drugs Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 29. Key Manufacturers Barbiturate Drugs Plants/Factories Distribution
Table 30. Key Manufacturers Barbiturate Drugs Area Served
Table 31. Date of Key Manufacturers Enter into Barbiturate Drugs Market
Table 32. Key Manufacturers Barbiturate Drugs Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Barbiturate Drugs Sales (MT) by Type (2017-2022)
Table 35. Global Barbiturate Drugs Sales Share by Type (2017-2022)
Table 36. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Barbiturate Drugs Price (MT) by Type (2017-2022)
Table 38. Global Barbiturate Drugs Sales (MT) by Type (2023-2028)
Table 39. Global Barbiturate Drugs Sales Share by Type (2023-2028)
Table 40. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Barbiturate Drugs Revenue Share by Type (2023-2028)
Table 42. Global Barbiturate Drugs Price (MT) by Type (2023-2028)
Table 43. Global Barbiturate Drugs Sales (MT) by Application (2017-2022)
Table 44. Global Barbiturate Drugs Sales Share by Application (2017-2022)
Table 45. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Barbiturate Drugs Price (MT) by Application (2017-2022)
Table 47. Global Barbiturate Drugs Sales (MT) by Application (2023-2028)
Table 48. Global Barbiturate Drugs Sales Share by Application (2023-2028)
Table 49. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Barbiturate Drugs Revenue Share by Application (2023-2028)
Table 51. Global Barbiturate Drugs Price (MT) by Application (2023-2028)
Table 52. North America Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 53. North America Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 54. North America Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 56. North America Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 57. North America Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 58. North America Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 61. North America Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 62. North America Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 65. North America Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 66. North America Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 69. Europe Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 70. Europe Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 72. Europe Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 73. Europe Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 74. Europe Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 77. Europe Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 78. Europe Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 81. Europe Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 82. Europe Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 85. Asia Pacific Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 89. Asia Pacific Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 90. Asia Pacific Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 93. Asia Pacific Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 94. Asia Pacific Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Barbiturate Drugs Sales by Region (2017-2022) & (MT)
Table 97. Asia Pacific Barbiturate Drugs Sales by Region (2023-2028) & (MT)
Table 98. Asia Pacific Barbiturate Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Barbiturate Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 101. Latin America Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 102. Latin America Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 104. Latin America Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 105. Latin America Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 106. Latin America Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 109. Latin America Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 110. Latin America Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 113. Latin America Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 114. Latin America Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 117. Middle East and Africa Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 121. Middle East and Africa Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 122. Middle East and Africa Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 125. Middle East and Africa Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 126. Middle East and Africa Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 129. Middle East and Africa Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 130. Middle East and Africa Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Overview
Table 134. Pfizer Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 135. Pfizer Barbiturate Drugs Product and Services
Table 136. Pfizer Barbiturate Drugs SWOT Analysis
Table 137. Pfizer Recent Developments
Table 138. Merck Corporation Information
Table 139. Merck Description and Overview
Table 140. Merck Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 141. Merck Barbiturate Drugs Product and Services
Table 142. Merck Barbiturate Drugs SWOT Analysis
Table 143. Merck Recent Developments
Table 144. Eli Lilly Corporation Information
Table 145. Eli Lilly Description and Overview
Table 146. Eli Lilly Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 147. Eli Lilly Barbiturate Drugs Product and Services
Table 148. Eli Lilly Barbiturate Drugs SWOT Analysis
Table 149. Eli Lilly Recent Developments
Table 150. Mylan Corporation Information
Table 151. Mylan Description and Overview
Table 152. Mylan Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 153. Mylan Barbiturate Drugs Product and Services
Table 154. Mylan Barbiturate Drugs SWOT Analysis
Table 155. Mylan Recent Developments
Table 156. Sanofi Corporation Information
Table 157. Sanofi Description and Overview
Table 158. Sanofi Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 159. Sanofi Barbiturate Drugs Product and Services
Table 160. Sanofi Barbiturate Drugs SWOT Analysis
Table 161. Sanofi Recent Developments
Table 162. Teva Pharmaceutical Corporation Information
Table 163. Teva Pharmaceutical Description and Overview
Table 164. Teva Pharmaceutical Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 165. Teva Pharmaceutical Barbiturate Drugs Product and Services
Table 166. Teva Pharmaceutical Barbiturate Drugs SWOT Analysis
Table 167. Teva Pharmaceutical Recent Developments
Table 168. Sumitomo Dainippon Pharma Corporation Information
Table 169. Sumitomo Dainippon Pharma Description and Overview
Table 170. Sumitomo Dainippon Pharma Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 171. Sumitomo Dainippon Pharma Barbiturate Drugs Product and Services
Table 172. Sumitomo Dainippon Pharma Barbiturate Drugs SWOT Analysis
Table 173. Sumitomo Dainippon Pharma Recent Developments
Table 174. Bausch Health Corporation Information
Table 175. Bausch Health Description and Overview
Table 176. Bausch Health Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 177. Bausch Health Barbiturate Drugs Product and Services
Table 178. Bausch Health Barbiturate Drugs SWOT Analysis
Table 179. Bausch Health Recent Developments
Table 180. Oak Pharmaceuticals Corporation Information
Table 181. Oak Pharmaceuticals Description and Overview
Table 182. Oak Pharmaceuticals Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 183. Oak Pharmaceuticals Barbiturate Drugs Product and Services
Table 184. Oak Pharmaceuticals Barbiturate Drugs SWOT Analysis
Table 185. Oak Pharmaceuticals Recent Developments
Table 186. Meda pharmaceuticals Corporation Information
Table 187. Meda pharmaceuticals Description and Overview
Table 188. Meda pharmaceuticals Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 189. Meda pharmaceuticals Barbiturate Drugs Product and Services
Table 190. Meda pharmaceuticals Barbiturate Drugs SWOT Analysis
Table 191. Meda pharmaceuticals Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Barbiturate Drugs Distributors List
Table 195. Barbiturate Drugs Customers List
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Barbiturate Drugs Product Picture
Figure 2. Global Barbiturate Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Ultra-Short Acting Barbiturate Product Picture
Figure 4. Short-Acting Barbiturate Product Picture
Figure 5. Long-Acting Barbiturate Product Picture
Figure 6. Combination Drugs Product Picture
Figure 7. Global Barbiturate Drugs Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacies Use Case
Figure 9. Retail Pharmacies Use Case
Figure 10. Online Pharmacies Use Case
Figure 11. Barbiturate Drugs Report Years Considered
Figure 12. Global Barbiturate Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Barbiturate Drugs Market Size 2017-2028 (US$ Million)
Figure 14. Global Barbiturate Drugs Sales (2017-2022) & (MT)
Figure 15. Global Barbiturate Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Barbiturate Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Barbiturate Drugs Sales Market Share by Region in 2021
Figure 18. Global Barbiturate Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Barbiturate Drugs Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Barbiturate Drugs Sales in 2021
Figure 21. Barbiturate Drugs Revenue Share by Manufacturers in 2021
Figure 22. Barbiturate Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Barbiturate Drugs Revenue Share by Type (2017-2022)
Figure 24. Global Barbiturate Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Barbiturate Drugs Revenue Share by Application (2017-2022)
Figure 26. Global Barbiturate Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 28. North America Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 29. North America Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 30. North America Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 31. North America Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 32. North America Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 33. U.S. Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 36. Europe Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Europe Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 38. Europe Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Europe Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 40. Europe Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 41. Germany Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. France Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Italy Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Russia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Asia Pacific Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 47. Asia Pacific Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 48. Asia Pacific Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 49. Asia Pacific Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 50. Asia Pacific Barbiturate Drugs Sales Share by Region (2017-2028)
Figure 51. Asia Pacific Barbiturate Drugs Revenue Share by Region (2017-2028)
Figure 52. China Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Japan Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. South Korea Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. India Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Australia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Taiwan Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Indonesia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Thailand Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Malaysia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Philippines Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Vietnam Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Latin America Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 64. Latin America Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 65. Latin America Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 66. Latin America Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 67. Latin America Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 68. Latin America Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 69. Mexico Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Brazil Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Argentina Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Middle East and Africa Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 77. Middle East and Africa Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 78. Turkey Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Saudi Arabia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. U.A.E Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Barbiturate Drugs Value Chain
Figure 82. Barbiturate Drugs Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

　

ページTOPに戻る


　

Summary

Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user’s brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.

Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Barbiturate Drugs manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Barbiturate Drugs market. Further, it explains the major drivers and regional dynamics of the global Barbiturate Drugs market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Bausch Health
Oak Pharmaceuticals
Meda pharmaceuticals

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Barbiturate Drugs Segment by Type
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
Barbiturate Drugs Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Barbiturate Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Barbiturate Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Barbiturate Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Barbiturate Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Barbiturate Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Barbiturate Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Barbiturate Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Merck, Eli Lilly, Mylan, Sanofi, Teva Pharmaceutical, Sumitomo Dainippon Pharma, Bausch Health and Oak Pharmaceuticals, etc.



ページTOPに戻る


Table of Contents

List of Tables
Table 1. Global Barbiturate Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ultra-Short Acting Barbiturate
Table 3. Major Manufacturers of Short-Acting Barbiturate
Table 4. Major Manufacturers of Long-Acting Barbiturate
Table 5. Major Manufacturers of Combination Drugs
Table 6. Global Barbiturate Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Barbiturate Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Barbiturate Drugs Sales by Region (2017-2022) & (MT)
Table 9. Global Barbiturate Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Barbiturate Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Barbiturate Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Barbiturate Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 13. Global Barbiturate Drugs Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Barbiturate Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Barbiturate Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Barbiturate Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Barbiturate Drugs Market Trends
Table 18. Barbiturate Drugs Market Drivers
Table 19. Barbiturate Drugs Market Challenges
Table 20. Barbiturate Drugs Market Restraints
Table 21. Global Barbiturate Drugs Sales by Manufacturers (2017-2022) & (MT)
Table 22. Global Barbiturate Drugs Sales Share by Manufacturers (2017-2022)
Table 23. Global Barbiturate Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Barbiturate Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 25. Barbiturate Drugs Revenue Share by Manufacturers (2017-2022)
Table 26. Global Barbiturate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Barbiturate Drugs as of 2021)
Table 28. Key Manufacturers Barbiturate Drugs Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 29. Key Manufacturers Barbiturate Drugs Plants/Factories Distribution
Table 30. Key Manufacturers Barbiturate Drugs Area Served
Table 31. Date of Key Manufacturers Enter into Barbiturate Drugs Market
Table 32. Key Manufacturers Barbiturate Drugs Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Barbiturate Drugs Sales (MT) by Type (2017-2022)
Table 35. Global Barbiturate Drugs Sales Share by Type (2017-2022)
Table 36. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Barbiturate Drugs Price (MT) by Type (2017-2022)
Table 38. Global Barbiturate Drugs Sales (MT) by Type (2023-2028)
Table 39. Global Barbiturate Drugs Sales Share by Type (2023-2028)
Table 40. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Barbiturate Drugs Revenue Share by Type (2023-2028)
Table 42. Global Barbiturate Drugs Price (MT) by Type (2023-2028)
Table 43. Global Barbiturate Drugs Sales (MT) by Application (2017-2022)
Table 44. Global Barbiturate Drugs Sales Share by Application (2017-2022)
Table 45. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Barbiturate Drugs Price (MT) by Application (2017-2022)
Table 47. Global Barbiturate Drugs Sales (MT) by Application (2023-2028)
Table 48. Global Barbiturate Drugs Sales Share by Application (2023-2028)
Table 49. Global Barbiturate Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Barbiturate Drugs Revenue Share by Application (2023-2028)
Table 51. Global Barbiturate Drugs Price (MT) by Application (2023-2028)
Table 52. North America Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 53. North America Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 54. North America Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 56. North America Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 57. North America Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 58. North America Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 61. North America Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 62. North America Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 65. North America Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 66. North America Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 69. Europe Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 70. Europe Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 72. Europe Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 73. Europe Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 74. Europe Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 77. Europe Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 78. Europe Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 81. Europe Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 82. Europe Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 85. Asia Pacific Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 89. Asia Pacific Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 90. Asia Pacific Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 93. Asia Pacific Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 94. Asia Pacific Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Barbiturate Drugs Sales by Region (2017-2022) & (MT)
Table 97. Asia Pacific Barbiturate Drugs Sales by Region (2023-2028) & (MT)
Table 98. Asia Pacific Barbiturate Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Barbiturate Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 101. Latin America Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 102. Latin America Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 104. Latin America Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 105. Latin America Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 106. Latin America Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 109. Latin America Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 110. Latin America Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 113. Latin America Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 114. Latin America Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Barbiturate Drugs Sales by Company (2017-2022) & (MT)
Table 117. Middle East and Africa Barbiturate Drugs Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Barbiturate Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Barbiturate Drugs Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Barbiturate Drugs Sales by Type (2017-2022) & (MT)
Table 121. Middle East and Africa Barbiturate Drugs Sales by Type (2023-2028) & (MT)
Table 122. Middle East and Africa Barbiturate Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Barbiturate Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Barbiturate Drugs Sales by Application (2017-2022) & (MT)
Table 125. Middle East and Africa Barbiturate Drugs Sales by Application (2023-2028) & (MT)
Table 126. Middle East and Africa Barbiturate Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Barbiturate Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Barbiturate Drugs Sales by Country (2017-2022) & (MT)
Table 129. Middle East and Africa Barbiturate Drugs Sales by Country (2023-2028) & (MT)
Table 130. Middle East and Africa Barbiturate Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Barbiturate Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Overview
Table 134. Pfizer Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 135. Pfizer Barbiturate Drugs Product and Services
Table 136. Pfizer Barbiturate Drugs SWOT Analysis
Table 137. Pfizer Recent Developments
Table 138. Merck Corporation Information
Table 139. Merck Description and Overview
Table 140. Merck Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 141. Merck Barbiturate Drugs Product and Services
Table 142. Merck Barbiturate Drugs SWOT Analysis
Table 143. Merck Recent Developments
Table 144. Eli Lilly Corporation Information
Table 145. Eli Lilly Description and Overview
Table 146. Eli Lilly Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 147. Eli Lilly Barbiturate Drugs Product and Services
Table 148. Eli Lilly Barbiturate Drugs SWOT Analysis
Table 149. Eli Lilly Recent Developments
Table 150. Mylan Corporation Information
Table 151. Mylan Description and Overview
Table 152. Mylan Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 153. Mylan Barbiturate Drugs Product and Services
Table 154. Mylan Barbiturate Drugs SWOT Analysis
Table 155. Mylan Recent Developments
Table 156. Sanofi Corporation Information
Table 157. Sanofi Description and Overview
Table 158. Sanofi Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 159. Sanofi Barbiturate Drugs Product and Services
Table 160. Sanofi Barbiturate Drugs SWOT Analysis
Table 161. Sanofi Recent Developments
Table 162. Teva Pharmaceutical Corporation Information
Table 163. Teva Pharmaceutical Description and Overview
Table 164. Teva Pharmaceutical Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 165. Teva Pharmaceutical Barbiturate Drugs Product and Services
Table 166. Teva Pharmaceutical Barbiturate Drugs SWOT Analysis
Table 167. Teva Pharmaceutical Recent Developments
Table 168. Sumitomo Dainippon Pharma Corporation Information
Table 169. Sumitomo Dainippon Pharma Description and Overview
Table 170. Sumitomo Dainippon Pharma Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 171. Sumitomo Dainippon Pharma Barbiturate Drugs Product and Services
Table 172. Sumitomo Dainippon Pharma Barbiturate Drugs SWOT Analysis
Table 173. Sumitomo Dainippon Pharma Recent Developments
Table 174. Bausch Health Corporation Information
Table 175. Bausch Health Description and Overview
Table 176. Bausch Health Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 177. Bausch Health Barbiturate Drugs Product and Services
Table 178. Bausch Health Barbiturate Drugs SWOT Analysis
Table 179. Bausch Health Recent Developments
Table 180. Oak Pharmaceuticals Corporation Information
Table 181. Oak Pharmaceuticals Description and Overview
Table 182. Oak Pharmaceuticals Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 183. Oak Pharmaceuticals Barbiturate Drugs Product and Services
Table 184. Oak Pharmaceuticals Barbiturate Drugs SWOT Analysis
Table 185. Oak Pharmaceuticals Recent Developments
Table 186. Meda pharmaceuticals Corporation Information
Table 187. Meda pharmaceuticals Description and Overview
Table 188. Meda pharmaceuticals Barbiturate Drugs Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 189. Meda pharmaceuticals Barbiturate Drugs Product and Services
Table 190. Meda pharmaceuticals Barbiturate Drugs SWOT Analysis
Table 191. Meda pharmaceuticals Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Barbiturate Drugs Distributors List
Table 195. Barbiturate Drugs Customers List
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Barbiturate Drugs Product Picture
Figure 2. Global Barbiturate Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Ultra-Short Acting Barbiturate Product Picture
Figure 4. Short-Acting Barbiturate Product Picture
Figure 5. Long-Acting Barbiturate Product Picture
Figure 6. Combination Drugs Product Picture
Figure 7. Global Barbiturate Drugs Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacies Use Case
Figure 9. Retail Pharmacies Use Case
Figure 10. Online Pharmacies Use Case
Figure 11. Barbiturate Drugs Report Years Considered
Figure 12. Global Barbiturate Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Barbiturate Drugs Market Size 2017-2028 (US$ Million)
Figure 14. Global Barbiturate Drugs Sales (2017-2022) & (MT)
Figure 15. Global Barbiturate Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Barbiturate Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Barbiturate Drugs Sales Market Share by Region in 2021
Figure 18. Global Barbiturate Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Barbiturate Drugs Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Barbiturate Drugs Sales in 2021
Figure 21. Barbiturate Drugs Revenue Share by Manufacturers in 2021
Figure 22. Barbiturate Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Barbiturate Drugs Revenue Share by Type (2017-2022)
Figure 24. Global Barbiturate Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Barbiturate Drugs Revenue Share by Application (2017-2022)
Figure 26. Global Barbiturate Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 28. North America Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 29. North America Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 30. North America Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 31. North America Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 32. North America Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 33. U.S. Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 36. Europe Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Europe Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 38. Europe Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Europe Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 40. Europe Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 41. Germany Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. France Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Italy Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Russia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Asia Pacific Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 47. Asia Pacific Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 48. Asia Pacific Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 49. Asia Pacific Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 50. Asia Pacific Barbiturate Drugs Sales Share by Region (2017-2028)
Figure 51. Asia Pacific Barbiturate Drugs Revenue Share by Region (2017-2028)
Figure 52. China Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Japan Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. South Korea Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. India Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Australia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Taiwan Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Indonesia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Thailand Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Malaysia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Philippines Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Vietnam Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Latin America Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 64. Latin America Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 65. Latin America Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 66. Latin America Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 67. Latin America Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 68. Latin America Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 69. Mexico Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Brazil Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Argentina Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Middle East and Africa Barbiturate Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Barbiturate Drugs Revenue Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Barbiturate Drugs Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Barbiturate Drugs Revenue Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Barbiturate Drugs Sales Share by Country (2017-2028)
Figure 77. Middle East and Africa Barbiturate Drugs Revenue Share by Country (2017-2028)
Figure 78. Turkey Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Saudi Arabia Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. U.A.E Barbiturate Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Barbiturate Drugs Value Chain
Figure 82. Barbiturate Drugs Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04　10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.